Crea il mio profilo
Accesso pubblico
Visualizza tutto9 articoli
0 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Olivier DenisSciensanoEmail verificata su proximus.be
- Dominique L. MonnetEuropean Centre for Disease Prevention and Control (ECDC)Email verificata su ecdc.europa.eu
- Hector Rodriguez-Villalobos, MD PhDChef de Service de microbiologie. Cliniques Universitaires Saint Luc. Professeur UCLouvainEmail verificata su uclouvain.be
- Alex van BelkumbioMerieuxEmail verificata su biomerieux.com
- Frederique Jacobshôpital ErasmeEmail verificata su erasme.ulb.ac.be
- David L. PatersonUniversity of QueenslandEmail verificata su uq.edu.au
- Matthew FalagasAlfa Institute Biomedical Sciences & Hygeia Hospital, Greece & Tufts Univ. Sch. Medicine, Boston, MAEmail verificata su aibs.gr
- Yehuda CarmeliNational Institute of Antibiotic Resistance and Infection Control, 6 Weizmann St. Tel Aviv, IsraelEmail verificata su tlvmc.gov.il
- J. Todd WeberCenters for Disease Control and PreventionEmail verificata su cdc.gov
- ALKIVIADIS VATOPOULOSUniversity of West AtticaEmail verificata su uniwa.gr
- Panayotis T. TassiosNational and Kapodistrian University of AthensEmail verificata su med.uoa.gr
- Prof. Dr. Alex W. FriedrichUniversity of Groningen, University Hospital Groningen, The NetherlandsEmail verificata su umcg.nl
- Robert SkovStatens Serum InstitutEmail verificata su ssi.dk
- Jean-Louis VincentUniversité libre de BruxellesEmail verificata su ulb.ac.be
- Norman Kenneth FryLaboratory Surveillance Lead – Vaccine Preventable Bacteria; UK Health Security AgencyEmail verificata su ukhsa.gov.uk
- Michel DelméeProfessorEmail verificata su uclouvain.be
- Fred C TenoverUniversity of DaytonEmail verificata su udayton.edu
- Patrick ButayeProfessor of MicrobiologyEmail verificata su Ugent.be
- Richard V. GoeringProfessor of Medical Microbiology and Immunology, Creighton UniversityEmail verificata su creighton.edu
- ian gouldaberdeenEmail verificata su modusmedica.com